Science
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) Is Up 19.46% From Its 52-Week Low; YTD, It Is Down -12.33% – What To Do Now
During the last session, Supernus Pharmaceuticals Inc (NASDAQ:SUPN)’s traded shares were 0.75 million, with the beta value of the company hitting 0.71. At the end
